According to recent research published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumor-inhibiting genetic cargo boosts the immune system and supports immunotherapy in reducing or totally eradicating aggressive tumours in mice. The findings pave the path
According to a new study published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumour-inhibiting genetic cargo promotes the immune system and aids immunotherapy in shrinking or completely clearing aggressive tumours in mice. The findings pave the way f
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.
Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.
Sanford Burnham Prebys' recent study has contributed to the understanding of how melanoma circumvents the immune system and may help in the development of future treatments for the condition. A protein that is known to be active in immune cells is also active inside melanoma cells, the study
A multi-centre study from Lawson Health Research Institute, the Centre Hospitalier de l'Universite de Montreal (CHUM), and the Jewish General Hospital (JGH) found that faecal microbiota transplants (FMT) from healthy donors are safe and show promise in improving response to immunotherapy in
The cancer immunotherapy atezolizumab1 significantly increased the overall survival of patients with advanced stage non-small cell lung cancer who were unable to receive platinum-containing chemotherapy when compared to single-agent chemotherapy, according to a global study conducted by UCL
Immunotherapy is a relatively new and successful cancer treatment. It causes the immune system to identify tumours as invaders and attack them. Immunotherapy, however, does not benefit all patients. Why? Scientists aren't always certain.
Sometimes, immunotherapy patients experience side eff